-
-
-
-
-
-
-
Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
-
-
-
-
-
-
-
Pre-Open Stock Movers 08/18: (SE) (RXT) (VNDA) Higher; (PSTX) (NBR) (KSS) Lower (more...)
-
-
-
-
-
-
-
Vanda and UCSF Announce License Agreement for CFTR Activators and Inhibitors
-
-
-
-
-
-
-
Unusual 11 Mid-Day Movers 12/23: (TECU) (PRLS) (NQ) Higher; (ACHN) (SKYS) (AGIO) Lower
-
-
-
-
-
-
-
Pre-Open Stock Movers 12/04: (OCLS) (PLUG) (OMED) Higher; (AMBI) (EXPR) (OVTI) Lower (more...)
-
-
-
-
923,810 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All